ALXN

Citigroup Joins the Financial Beats: Monday’s IP Market Recap

Citigroup's earnings beat helped give financials another push Monday, and the Dow and S&P 500 each inched to new record highs. More 

3 Bullish Biotech Stocks for 3 Trading Timeframes

These pharmaceutical stocks have very bullish technicals for the short-, intermediate- and long-term. Keep an eye on these charts for confirmation of the trends. More 

What To Make Of Tuesday’s Surprising Market Move

Wall Street clearly made up for the shortened trading week with a broad rally on Tuesday. Here's our new research on 50 stocks in Portfolio Grader More 

46 Stock Bellwethers on the Move

There is no doubt the upcoming first-quarter earnings announcement season is going to separate the wheat from the chaff and here are 46 stocks with new ratings More 

Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)

Looking for a non-correlated asset to beat the market in a potential downturn? Look no further than biotech stock Regeneron Pharmaceuticals (REGN). More 

Bull’s Eye Report: Regeneron Pharmaceuticals (REGN)

REGN gained 208.65% on the year in 2012, and while normally this would indicate a parabolic run, the short-term prospects for a trade still look pretty good. More 

Put Credit Spread on Alexion Pharmaceuticals Inc. (ALXN)

Here is a trade idea that considers a continued bullish trend, but also has a double back-up plan just in case. More